bpc 157 buy europe BPC-157 BPC - 157 :: Aurapeptides
Description
A typical transitional protocol might involve four weeks at 0.25 mg daily, followed by two weeks at 0.15 mg daily, then maintenance at 0.1 mg daily for extended periods
There is an association with "watermelon stomach" (GAVE) and pernicious anemia
Severe hepatic impairment may influence the suitability of this medication for certain patients
Animal studies used doses up to 1.1 mg per kilogram of body weight with no adverse effects observed
